Aptevo Therapeutics Inc. Cash
Aptevo Therapeutics Inc. (APVO) had Cash of $1.62 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-14
- 2026-06-30: Cash $1.62M.
- 2026-03-31: Cash $856.00K.
- 2025-12-31: Cash $1.12M.
- 2025-09-30: Cash $3.23M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $1.62M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $856.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.12M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $3.23M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $8.10M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $855.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.18M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $1.97M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $962.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $663.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $3.73M 10-K · filed 2025-02-14 | $3.73M 10-K · filed 2024-03-05 |
| 2023-09-30 | $1.60M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.03M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.48M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.07M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $3.73M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.50M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.99M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $3.84M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $4.22M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $4.50M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $26.63M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $4.60M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $1.56M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $2.02M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $2.72M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $4.95M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $7.26M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $4.65M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $7.86M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $6.59M 10-K · filed 2020-03-25 | $29.05M 10-K · filed 2019-03-18 |
| 2018-09-30 | $24.33M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $4.16M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $7.59M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $6.10M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |